A Maintenance Therapy Study of Odetiglucan With CDX-1140 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Clinical trial NCT05484011 · TERMINATED

Trial details

NCT number: NCT05484011
Sponsor: HiberCell, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Pancreatic Adenocarcinoma

Start date: 2022-12-15
Primary completion: 2024-03-04
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.